DEA Scheduled vs Non-Controlled Materials

Regulatory status of materials commonly used in research studies

Enacted November 2025, the Fiscal Year 2026 Agriculture Appropriations bill changed the regulatory status of many cannabis-based research materials. R3CR will provide up-to-date information on these changing regulations that will go into effect on November 12, 2026.

The following examples of materials commonly used in research studies are listed with the regulatory status of each as currently interpreted by R3CR:

DEA-Controlled Examples

DEA Controlled

Schedule

Drug Code

 NOTE

Tetrahydrocannabinol Class of Cannabinoids

  • Delta-8 tetrahydrocannabinol
  • Delta-9 tetrahydrocannabinol
  • Other tetrahydrocannabinols

C-I 7370

Either natural or synthesized pure compounds and solutions of these compounds.

 

Synthetic derivatives of these are C-I.
Marijuana Plant Material

C-I 7360

 >0.3% THC

Plant Extract >0.3% THC

  • Marijuana Extract
  • Hemp Extract

C-I 7350

 >0.3% THC
Marijuana Cigarettes >0.3% THC

C-I 7360

 Placebo cigarettes are not controlled.
Marijuana Seeds

C-I 7360

 From drug-type marijuana plants
Dronabinol Capsules C-III 7379 Products approved by FDA

Not DEA-Controlled Examples

Not DEA Controlled NOTE

Hemp-derived Cannabinoids

  • Cannabidiol (CBD)
  • Cannabinol (CBN)
  • Cannabichromene (CBC)
  • Cannabidivarin (CBDV)
  • Cannabicitran (CBT)
  • Cannabigerol (CBG)

Purified compounds derived from plants and solutions of these compounds.

≤0.3% THC

Synthetic Cannabinoids not in Tetrahydrocannabinol Class

  • Synthetic versions of naturally occurring cannabinoids

Synthetic compounds and solutions of these compounds.

≤0.3% THC

Hemp Plant Material

  • Dried hemp
  • Living hemp plants
  • Hemp seeds (viable and non-viable)
 ≤0.3% THC

Hemp Extract

  • Intermediate Hemp Products
 ≤0.3% THC
Epidiolex® Cannabidiol product approved by FDA.